Literature DB >> 19499323

Polysaccharides from wolfberry antagonizes glutamate excitotoxicity in rat cortical neurons.

Yuen-Shan Ho1, Man-Shan Yu, Suet-Yi Yik, Kwok-Fai So, Wai-Hung Yuen, Raymond Chuen-Chung Chang.   

Abstract

Glutamate excitotoxicity is involved in many neurodegenerative diseases including Alzheimer's disease (AD). Attenuation of glutamate toxicity is one of the therapeutic strategies for AD. Wolfberry (Lycium barbarum) is a common ingredient in oriental cuisines. A number of studies suggest that wolfberry has anti-aging properties. In recent years, there is a trend of using dried Wolfberry as food supplement and health product in UK and North America. Previously, we have demonstrated that a fraction of polysaccharide from Wolfberry (LBA) provided remarkable neuroprotective effects against beta-amyloid peptide-induced cytotoxicity in primary cultures of rat cortical neurons. To investigate whether LBA can protect neurons from other pathological factors such as glutamate found in Alzheimer brain, we examined whether it can prevent neurotoxicity elicited by glutamate in primary cultured neurons. The glutamate-induced cell death as detected by lactate dehydrogenase assay and caspase-3-like activity assay was significantly reduced by LBA at concentrations ranging from 10 to 500 microg/ml. Protective effects of LBA were comparable to memantine, a non-competitive NMDA receptor antagonist. LBA provided neuroprotection even 1 h after exposure to glutamate. In addition to glutamate, LBA attenuated N-methyl-D-aspartate (NMDA)-induced neuronal damage. To further explore whether LBA might function as antioxidant, we used hydrogen peroxide (H(2)O(2)) as oxidative stress inducer in this study. LBA could not attenuate the toxicity of H(2)O(2). Furthermore, LBA did not attenuate glutamate-induced oxidation by using NBT assay. Western blot analysis indicated that glutamate-induced phosphorylation of c-jun N-terminal kinase (JNK) was reduced by treatment with LBA. Taken together, LBA exerted significant neuroprotective effects on cultured cortical neurons exposed to glutamate.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19499323     DOI: 10.1007/s10571-009-9419-x

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  60 in total

1.  Distinct mechanisms underlie distinct polyphenol-induced neuroprotection.

Authors:  Keiko Yazawa; Takeshi Kihara; Huilian Shen; Yoshiari Shimmyo; Tetsuhiro Niidome; Hachiro Sugimoto
Journal:  FEBS Lett       Date:  2006-11-14       Impact factor: 4.124

2.  Thrombin-induced oxidative stress contributes to the death of hippocampal neurons in vivo: role of microglial NADPH oxidase.

Authors:  Sang-Ho Choi; Da Yong Lee; Seung Up Kim; Byung Kwan Jin
Journal:  J Neurosci       Date:  2005-04-20       Impact factor: 6.167

Review 3.  Molecular mechanism of neuronal plasticity: induction and maintenance of long-term potentiation in the hippocampus.

Authors:  Eishichi Miyamoto
Journal:  J Pharmacol Sci       Date:  2006       Impact factor: 3.337

Review 4.  New targets for pharmacological intervention in the glutamatergic synapse.

Authors:  Fabrizio Gardoni; Monica Di Luca
Journal:  Eur J Pharmacol       Date:  2006-06-15       Impact factor: 4.432

Review 5.  Antioxidant therapy in acute central nervous system injury: current state.

Authors:  Yossi Gilgun-Sherki; Ziv Rosenbaum; Eldad Melamed; Daniel Offen
Journal:  Pharmacol Rev       Date:  2002-06       Impact factor: 25.468

Review 6.  Disease modifying therapy for AD?

Authors:  Todd E Golde
Journal:  J Neurochem       Date:  2006-11       Impact factor: 5.372

7.  Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity.

Authors:  Jianfei Chao; Man-Shan Yu; Yuen-Shan Ho; Mingfu Wang; Raymond Chuen-Chung Chang
Journal:  Free Radic Biol Med       Date:  2008-07-16       Impact factor: 7.376

8.  Reduction of calcium release from the endoplasmic reticulum could only provide partial neuroprotection against beta-amyloid peptide toxicity.

Authors:  Ka-Chun Suen; Kim-Fung Lin; Wassim Elyaman; Kwok-Fai So; Raymond Chuen-Chung Chang; Jacques Hugon
Journal:  J Neurochem       Date:  2003-12       Impact factor: 5.372

Review 9.  Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions.

Authors:  David J Gladstone; Sandra E Black; Antoine M Hakim
Journal:  Stroke       Date:  2002-08       Impact factor: 7.914

Review 10.  Oxidative stress, glutamate, and neurodegenerative disorders.

Authors:  J T Coyle; P Puttfarcken
Journal:  Science       Date:  1993-10-29       Impact factor: 47.728

View more
  43 in total

1.  The neurotoxicity induced by PM2.5 might be strongly related to changes of the hippocampal tissue structure and neurotransmitter levels.

Authors:  Qingzhao Li; Jiali Zheng; Sheng Xu; Jingshu Zhang; Yanhua Cao; Zhenlong Qin; Xiaoqin Liu; Chunyang Jiang
Journal:  Toxicol Res (Camb)       Date:  2018-07-31       Impact factor: 3.524

Review 2.  The role of phytochemicals in the treatment and prevention of dementia.

Authors:  Melanie-Jayne R Howes; Elaine Perry
Journal:  Drugs Aging       Date:  2011-06-01       Impact factor: 3.923

3.  Protective effects of paeoniflorin against glutamate-induced neurotoxicity in PC12 cells via antioxidant mechanisms and Ca(2+) antagonism.

Authors:  Qing-Qiu Mao; Xiao-Ming Zhong; Chun-Rong Feng; Ai-Juan Pan; Zhao-Yi Li; Zhen Huang
Journal:  Cell Mol Neurobiol       Date:  2010-06-25       Impact factor: 5.046

Review 4.  A review of the anticancer and immunomodulatory effects of Lycium barbarum fruit.

Authors:  Wai-Man Tang; Enoch Chan; Ching-Yee Kwok; Yee-Ki Lee; Jian-Hong Wu; Chun-Wai Wan; Robbie Yat-Kan Chan; Peter Hoi-Fu Yu; Shun-Wan Chan
Journal:  Inflammopharmacology       Date:  2011-12-22       Impact factor: 4.473

Review 5.  An evidence-based update on the pharmacological activities and possible molecular targets of Lycium barbarum polysaccharides.

Authors:  Jiang Cheng; Zhi-Wei Zhou; Hui-Ping Sheng; Lan-Jie He; Xue-Wen Fan; Zhi-Xu He; Tao Sun; Xueji Zhang; Ruan Jin Zhao; Ling Gu; Chuanhai Cao; Shu-Feng Zhou
Journal:  Drug Des Devel Ther       Date:  2014-12-17       Impact factor: 4.162

Review 6.  Neuro-protective Mechanisms of Lycium barbarum.

Authors:  Xiwen Xing; Fenyong Liu; Jia Xiao; Kwok Fai So
Journal:  Neuromolecular Med       Date:  2016-03-31       Impact factor: 3.843

7.  Effect of nano-selenium loaded with lycium barbarum polysaccharide on the proliferation of lens epithelial cells after UVB damage in vitro.

Authors:  Jing-Xiang Zhong; Shan-Shan Jin; Kang-Sheng Wu; Guo-Cheng Yu; Lei-Lei Tu; Lian Liu
Journal:  Int J Ophthalmol       Date:  2022-01-18       Impact factor: 1.779

8.  Protection of retinal ganglion cells and retinal vasculature by Lycium barbarum polysaccharides in a mouse model of acute ocular hypertension.

Authors:  Xue-Song Mi; Qian Feng; Amy Cheuk Yin Lo; Raymond Chuen-Chung Chang; Bin Lin; Sookja Kim Chung; Kwok-Fai So
Journal:  PLoS One       Date:  2012-10-19       Impact factor: 3.240

9.  The effect of Lycium barbarum on spinal cord injury, particularly its relationship with M1 and M2 macrophage in rats.

Authors:  Yu-Kai Zhang; Jian Wang; Ling Liu; Raymond Chuen-Chung Chang; Kwok-Fai So; Gong Ju
Journal:  BMC Complement Altern Med       Date:  2013-03-22       Impact factor: 3.659

10.  The effects of Gouqi extracts on Morris maze learning in the APP/PS1 double transgenic mouse model of Alzheimer's disease.

Authors:  Qianlin Zhang; Xiaoping DU; Yuping Xu; Lei Dang; Li Xiang; Jiewen Zhang
Journal:  Exp Ther Med       Date:  2013-03-14       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.